RYVYL Signs MOU with Investor to Retire 8% Senior Convertible Note and Series B Convertible Preferred Stock
GlobeNewswire News Room· 2024-11-11 20:00
SAN DIEGO, CA, Nov. 11, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic payment technology for diverse international markets, has signed a non-binding Memorandum of Understanding (the “MOU”) with the investor (the “Investor”) setting forth the terms agreed to by the Company and the Investor for the full repayment and termination of an 8% Senior Convertible Note (the “No ...
Agora, Inc. to Report Third Quarter 2024 Financial Results on November 25, 2024
GlobeNewswire News Room· 2024-11-11 20:00
SANTA CLARA, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ: API), a pioneer and leader in real-time engagement technology, will release its financial results for the third quarter ended September 30, 2024 after the close of U.S. markets on November 25, 2024. Agora, Inc. will host a conference call to discuss the financial results at 5 p.m. Pacific Time / 8 p.m. Eastern Time on the same day. Details for the conference call are as follows: Event title: Agora, Inc. 3Q 2024 Financial Results The ...
Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial
GlobeNewswire News Room· 2024-11-11 20:00
Orphan Drug Designation has been granted lately by US FDA RAMAT GAN, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announces the dosing of the first patient in the Phase IIa clinical trial in patients with advanced pancreatic adenocarcinoma (NCT06387342). “We are excited to have the first patient enrolled and hope ...
Climb Bio Appoints Douglas E. Williams, Ph.D.
GlobeNewswire News Room· 2024-11-11 20:00
WELLESLEY, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its Board of Directors. Dr. Williams will assume the role of Chair of the Board, succeeding Andrew Levin, who will remain on the Board as a director, while Liam Ratcliffe will step down from his position as a director. Dr. Williams has over 30 years of executive leadership experience in the biotechnology sector. Throughout his career, Dr. W ...
Tecnoglass to Attend the Baird 2024 Global Industrial Conference
GlobeNewswire News Room· 2024-11-11 20:00
Miami, FL, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that the Company will attend the Baird 2024 Global Industrial Conference in Chicago, IL on Wednesday, November 13, 2024. About Tecnoglass Tecnoglass Inc. is a leading producer of high-end aluminum and vinyl windows and architectural glass serving the ...
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
Prnewswire· 2024-11-11 20:00
R&D Systems Hematology Controls and Calibrators has completed the Class C Certification under the new European Union In Vitro Diagnostic RegulationMINNEAPOLIS, Nov. 11, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) has recently achieved In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology Controls and Calibrators. This certification confirms that the products comply with the regulations and guidelines set forth by the European Union for in-vitro diagnostic devices. ...
Compugen to Participate in Stifel 2024 Healthcare Conference
Prnewswire· 2024-11-11 20:00
HOLON, Israel, Nov. 11, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that Compugen management will participate in a fireside chat at the upcoming Stifel 2024 Healthcare Conference in New York City. The fireside chat will take place on Monday, November 18, 2024 at 8:35 am ET.A live webcast will be accessible on the Investor Relations section of the Compugen website at www.cgen.com. ...
Hot Chili Adds La Verde Cu Mine to its Costa Fuego Coastal Copper Hub, Drilling Underway
Prnewswire· 2024-11-11 20:00
La Verde comprises significant historical open pit workings, where shallow porphyry copper oxide mineralisation was previously exploited by private interests across a strike extent of approximately 800m, widths of up to 200m and depths of up to 15m. Historical drilling was limited to the surrounding leases, with little to no drilling undertaken across the mine area. Importantly, La Verde sits in the centre of Hot Chili's recently consolidated and larger Domeyko landholding, secured in an Option Agreement ...
MONTROSE ENVIRONMENTAL GROUP TO ATTEND THE BAIRD 2024 GLOBAL INDUSTRIAL CONFERENCE
Prnewswire· 2024-11-11 20:00
LITTLE ROCK, Ark., Nov. 11, 2024 /PRNewswire/ -- Montrose Environmental Group, Inc. (the "Company," "Montrose" or "MEG") (NYSE: MEG) today announced that the Company will attend the Baird 2024 Global Industrial Conference in Chicago, IL on Tuesday, November 12, 2024. In conjunction with Montrose's attendance at this conference, the Company will post a copy of the presentation it intends to use in the Investors section of its website.About MontroseMontrose is a leading environmental solutions company focused ...
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
Prnewswire· 2024-11-11 20:00
Conference call and webcast to take place on Tuesday, November 12, 2024, at 8:30 a.m. ETSAN DIEGO and CALGARY, AB, Nov. 11, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it will host a conference call and webcast on Tuesday, November 12, 2024, at 8:30 a.m. ET to discuss a corporate update and financial results for the third quarter 2024.Conference Call & WebcastDate: Tuesday, November ...